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Bone marrow properties
 Bone marrow is a highly cellular structure present within the
hollow cavities of hard bone tissue
 There are 2 types of bone marrow:
A) Red bone marrow
B) Yellow bone marrow
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• Children: bone marrow in all bones is red bone marrow
• Adulthood: bone marrow cells in long bones of hand and leg
become non-functional and are replaced by fat cells to form
yellow bone marrow
• The only bone to carry red bone marrow throughout life are
vertebrae, sternum, hip bone and skull bones
Constitutes 4% of the total body mass of human
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• Bone marrow cells are highly functional and continuously
divide and give rise to the different cells present in blood.
• Changes in bone marrow cause change in the composition of
blood which can lead to various diseases. [1]
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What Are Stem Cells?
• An undifferentiated cell of a multicellular organism.
• Remarkable potential to develop into different cell types.
• Capable of giving rise to more cells of the same type.
• Other kinds of cell arise by differentiation.
• Capacity to self-renew.
• Potency (Toti / Pluri / Multi / Unipotent)[2]
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Potency 
9
• Totipotent: zygote / any cell / whole body / three layers
• Pluripotent: toti-derived / ESCs / not whole body / multipotent
cells
• Multipotent: pluri-derived / ASCs (HSCs and MSCs)
• Unipotent or Committed: one type / self-renewal / tissue-
specific stem cells[2,3]
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 Non-hematopoietic multipotent cells in the stromal 
compartment of the bone marrow were first identified by 
Friedenstein and colleagues.
 Have high proliferative potential and the ability to differentiate 
into chondrocytes, osteoblasts, adipocytes, and stromal cells 
that support hematopoiesis . Furthermore, they have 
immunomodulatory activity
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Criteria for the identification of MSCs from International
Society for Cellular Therapy (ISCT):
(1) Adherence to plastic
(2) Differentiation into chondrocytes, osteoblasts, and adipocytes
under standard in vitro differentiating conditions
(3) Expression of surface markers CD105, CD73, and CD90, in
the absence of CD45, CD34, CD14, CD11b, CD79α, CD19, and
HLA-DR [4]
12
13
BMSCs may be an important MSC population to consider for three
reasons.
First: their activity supports another distinct population of
progenitor cells that give rise to blood cells and immune system:
hematopoietic progenitors .
Second: BMSCs could be used to encourage repair of
extramedullary tissues
Third: BMSCs may influence bone growth and remodeling
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It has been divided into three stages :
 Days 1 to 4 :peak in the number of cells is seen.
 Days 5 to 14: characterized by the transcription and protein
expression of alkaline phosphatase (ALP). After this initial peak of
ALP its level starts to decline. Also found at an early stage is the
expression of a collagen type I matrix onto which the mineral is
deposited.
 Days 14 to 28: high expression of osteocalcin and osteopontin,
followed by calcium and phosphate deposition. [5]
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While MSC differentiation can be directed by multiple
microenvironmental factors (such as mechanical forces ,
electrical currents , and magnetic fields(, but we will specifically
focus on cytokine signaling that govern MSC lineage
differentiation.
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The commitment and differentiation of MSC towards an adipogenic
or osteogenic cell fate depend on a variety of signaling and
transcription factors. A large body of experimental evidence
suggests that an inverse correlation exists between adipogenesis
and osteogenesis [6]
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Factors involved in determination of BMSCs commitment into 
Osteoblast [9]
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Several cell signaling cascades exemplify proosteogenic/
antiadipocytic stimuli that include:
• 𝛽-catenin dependent Wnt signaling (as well as 𝛽-catenin
independent signaling)
• Hedgehog signaling
• NELL-1 (NEL-like protein 1) signaling
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Dissimilarly, various signaling cascades demonstrate positive
regulation of both osteogenesis and adipogenesis
• Bone morphogenetic proteins (BMPs):While the majority of
BMPs promotes osteogenic commitment and differentiation of
MSC BMPs also demonstrate proadipogenic effects
• Insulin like growth factor (IGF) signaling : likewise
demonstrates dual proosteogenic/proadipogenic effects
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Control of Adipogenesis and
Osteogenesis by Transcription Factor
Signaling cascades which promote MSC osteogenic and/or
adipogenic lineage differentiation generally converge on two key
transcription factors
• Runx2:The Master Osteogenic Transcription Factor
• PPAR𝛾:The Master Adipogenic Transcription Factor
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Runx2
In regard to osteogenic differentiation, Runx2 activates and
regulates osteogenesis as the targeted gene of many signaling
pathways, including but not limited to transforming growth
factor-beta 1 (TGF-𝛽1),BMP, Wingless type (Wnt), Hedgehog
(HH), and (Nel)-like protein type 1 (NELL-1)
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PPAR𝛾
 Peroxisome proliferator-activated receptors are members of the
steroid/thyroid hormone receptor gene superfamily
 All three PPARs are found in mammals and are activated by
poly unsaturate fatty acids
 PPAR𝛾 is principally regarded as the master regulator of
adipogenesis, for no other factor can rescue adipocyte formation
in the event of PPAR𝛾 knockout, and generally all proadipogenic
cell signaling pathways converge with PPAR𝛾[7]
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Yaccoby S. The role of the proteasome in bone formation and osteoclastogenesis. IBMS 
BoneKEy. 2010;7(4):147-55.
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Cell morphology and cytochemical characteristics
 Adhere to the bottom of the culture dish after 4 to 24 h.
On day 3: possess typical shapes, arranged linearly in a stepping-
stone arrangement
 Cell numbers increased gradually and reached confluence on
day6. Hematoxylin-eosin staining images showed that the nuclei
were stained an amethyst color and the cytoplasm was stained
pink Cell proliferation was determined with a kit
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 Calcification nod staining was investigated by the Alizarin
RedS staining method.Alizarin red calcium deposition was
measured at day 21.Mineralized matrix, indicated by bright red
staining was identified by light microscopy.
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Alkaline phosphatase (ALP) activity
 ALP activity was increased when co-cultured with osteoblasts,
compared with negative control group
 ALP activity in HUMSCs was determined at 7, 10 and 14 days
of incubation using alkaline phosphatase activity colorimetric
assay kit
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The expression of type I collagen protein
In the HUMSC co-cultured with different osteoblasts for 10 days,
the human-specific type I collagen antibody clearly revealed type
I collagen protein expression. The expression of type I collagen
protein was indicated by bright red fluorescence, cell nuclear
staining was indicated by blue fluorescence.
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The mRNA expression of OCN
HUMSCs co-culture with the osteoblasts induced the expression 
of OCN, which were nearly undetectable in the negative control 
group.
To assess the osteogenesis of HUMSCs, osteocalcin(OCN) 
mRNA expression was detected by real time RT-PCR 21days 
after cell co-culture [8]
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A: Morphology of osteoblasts
B: Hematoxylin-eosin staining
C: Expression of type I collagen
D: ALP staining
E: Alizarin Red S staining
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